|
Anemia
|
0.500 |
Biomarker
|
disease |
HPO |
|
|
|
|
Anemia
|
0.500 |
Biomarker
|
disease |
BEFREE |
Specific binding of erythropoietin to spleen cells infected with the anemia strain of Friend virus.
|
6095306 |
1984 |
|
Anemia
|
0.500 |
Biomarker
|
disease |
BEFREE |
The binding of labeled erythropoietin (EP) to cell surface receptors and subsequent processing of the hormone within the cell was studied in erythroid cells procured from the spleens of mice infected with the anemia strain of Friend virus.
|
3032937 |
1987 |
|
Anemia
|
0.500 |
AlteredExpression
|
disease |
BEFREE |
This anemia was also associated with low serum iron and normal iron stores and increased erythropoietin levels.
|
2486284 |
1989 |
|
Anemia
|
0.500 |
AlteredExpression
|
disease |
BEFREE |
Anemia induced increased human erythropoietin RNA levels in liver but not kidney.
|
2928334 |
1989 |
|
Anemia
|
0.500 |
Biomarker
|
disease |
CTD_human |
These results suggest that rHu Epo might be useful for the therapy of anaemia associated with anticancer chemotherapy.
|
2206997 |
1990 |
|
Anemia
|
0.500 |
Therapeutic
|
disease |
CTD_human |
These findings indicate that the anaemia induced by gentamicin is due not only to a deficiency of EPO but also to an enhancement of fragility of erythrocytes in an azotaemic environment.
|
1982298 |
1990 |
|
Anemia
|
0.500 |
Therapeutic
|
disease |
CTD_human |
Recombinant human erythropoietin for patients with AIDS treated with zidovudine.
|
2186273 |
1990 |
|
Anemia
|
0.500 |
Biomarker
|
disease |
CTD_human |
Recombinant human erythropoietin for patients with AIDS treated with zidovudine.
|
2186273 |
1990 |
|
Anemia
|
0.500 |
Therapeutic
|
disease |
CTD_human |
These results suggest that rHu Epo might be useful for the therapy of anaemia associated with anticancer chemotherapy.
|
2206997 |
1990 |
|
Anemia
|
0.500 |
Biomarker
|
disease |
CTD_human |
These findings indicate that the anaemia induced by gentamicin is due not only to a deficiency of EPO but also to an enhancement of fragility of erythrocytes in an azotaemic environment.
|
1982298 |
1990 |
|
Anemia
|
0.500 |
Therapeutic
|
disease |
CTD_human |
Protection of zidovudine-induced toxicity against murine erythroid progenitor cells by vitamin E.
|
1893952 |
1991 |
|
Anemia
|
0.500 |
AlteredExpression
|
disease |
BEFREE |
Human erythropoietin gene expression in liver and kidney is inducible by anemia or hypoxia.
|
2062846 |
1991 |
|
Anemia
|
0.500 |
Biomarker
|
disease |
CTD_human |
Protection of zidovudine-induced toxicity against murine erythroid progenitor cells by vitamin E.
|
1893952 |
1991 |
|
Anemia
|
0.500 |
Biomarker
|
disease |
BEFREE |
Synthesis of erythropoietin, the primary humoral regulator of erythropoiesis, in liver and kidney is inducible by anemia or hypoxia.
|
1924331 |
1991 |
|
Anemia
|
0.500 |
Therapeutic
|
disease |
CTD_human |
We compared blood pressure after three different methods of partial correction of anemia in hemodialysis patients with similar baseline hematocrits (erythropoietin n = 12, intravenous iron alone n = 10, androgens n = 9).
|
1516988 |
1992 |
|
Anemia
|
0.500 |
Biomarker
|
disease |
CTD_human |
Recombinant human erythropoietin in patients with ovarian carcinoma and anaemia secondary to cisplatin and carboplatin chemotherapy: preliminary results.
|
1574960 |
1992 |
|
Anemia
|
0.500 |
Therapeutic
|
disease |
CTD_human |
Recombinant human erythropoietin in patients with ovarian carcinoma and anaemia secondary to cisplatin and carboplatin chemotherapy: preliminary results.
|
1574960 |
1992 |
|
Anemia
|
0.500 |
Biomarker
|
disease |
CTD_human |
We compared blood pressure after three different methods of partial correction of anemia in hemodialysis patients with similar baseline hematocrits (erythropoietin n = 12, intravenous iron alone n = 10, androgens n = 9).
|
1516988 |
1992 |
|
Anemia
|
0.500 |
Biomarker
|
disease |
BEFREE |
These results suggest that impaired production of Epo may be a direct effect of HIV-1 infection possibly contributing to anemia in AIDS.
|
8390370 |
1993 |
|
Anemia
|
0.500 |
GeneticVariation
|
disease |
BEFREE |
The 5'-flanking region of the human erythropoietin (Epo) gene contains a 0.14-kb sequence that is conserved in the Epo gene from mouse and located within a promoter that is activated under hypoxic conditions such as anemia.
|
8486613 |
1993 |
|
Anemia
|
0.500 |
Biomarker
|
disease |
BEFREE |
Recombinant human granulocyte-macrophage colony-stimulating factor plus recombinant human erythropoietin may improve anemia in selected patients with myelodysplastic syndromes.
|
8237992 |
1993 |
|
Anemia
|
0.500 |
Biomarker
|
disease |
CTD_human |
The use of recombinant human erythropoietin to prevent carboplatin-induced anemia.
|
8504984 |
1993 |
|
Anemia
|
0.500 |
Therapeutic
|
disease |
CTD_human |
Clinical studies have shown recombinant human erythropoietin (r-HuEPO) to be effective in correcting the anemia of zidovudine-treated patients infected with human immunodeficiency virus with baseline serum erythropoietin levels of 500 U/L or less.
|
8250662 |
1993 |
|
Anemia
|
0.500 |
Biomarker
|
disease |
CTD_human |
Administration of a lower Epo dose (1 U Epo) resulted in only a modest retardation of AZT-induced anemia, although, when combined with heme, there was a great improvement in recovery of erythropoiesis.
|
8260696 |
1993 |